SCHEMBL976195

SCHEMBL976195

OCC1=NCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5108997 1.00
SCHEMBL215851 0.80
Alcohol SCHEMBL28228159 0.78 ADRA2A (0.30)
SCHEMBL329002 0.78 ADRA2A (0.34)
SCHEMBL351538 0.78 ADRA2A (0.34)
SCHEMBL6244828 0.75
SCHEMBL7933464 0.75
SCHEMBL7912667 0.75
SCHEMBL11687684 0.75
SCHEMBL14917574 0.74 ADRA2A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116715699-A Oxazoline chiral N, P ligand, preparation method and application thereof 无锡学院 2023-09-08 CN claimed
US-10968343-B2 Formaldehyde-free curable formulation ROHM AND HAAS COMPANY (US) 2021-04-06 US claimed
EP-2814489-A1 COMPOSITIONS AND METHODS FOR THE MODULATION OF SPECIFIC AMIDASES FOR N-ACYLETHANOLAMINES FOR USE IN THE THERAPY OF INFLAMMATORY DISEASES Epitech Group S.r.l. (IT) 2014-12-24 EP claimed
WO-2013121449-A1 COMPOSITIONS AND METHODS FOR THE MODULATION OF SPECIFIC AMIDASES FOR N-ACYLETHANOLAMINES FOR USE IN THE THERAPY OF INFLAMMATORY DISEASES EPITECH GROUP S.R.L. (IT) 2013-08-22 WO claimed
EP-1951686-B1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM IND CO LTD (KR) 2013-04-03 EP claimed
US-20080318950-A1 Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof HANMI PHARM. CO., LTD (KR) 2008-12-25 US claimed
EP-1951686-A1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF Hanmi Pharm. Co., Ltd. (KR) 2008-08-06 EP claimed
WO-2007055514-A1 QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2007-05-18 WO claimed
US-20020193361-A1 Epothilone derivatives and methods for making and using the same KOSAN BIOSCIENCES, INC. 2002-12-19 US claimed
US-6489314-B1 DUE TO THE INCREASING INTEREST IN EPOTHILONES AS ANTI-CANCER AGENTS, NOVEL DERIVATIVES OF THESE COMPOUNDS ARE NEEDED AND DESIRED TO MORE FULLY DEVELOP THEIR THERAPEUTIC POTENTIAL KOSAN BIOSCIENCES, INC. 2002-12-03 US claimed
EP-0907668-B1 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM NOVARTIS AG (CH) 2001-09-19 EP claimed
CN-1223673-A Amphiphilic, segmented copolymer of controlled morphology and ophthalmic devices including contact lenses made therefrom NOVARTIS AG (CH) 1999-07-21 CN claimed
EP-0907668-A1 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM Novartis AG (CH) 1999-04-14 EP claimed
US-5807944-A Amphiphilic, segmented copolymer of controlled morphology and ophthalmic devices including contact lenses made therefrom CIBA VISION CORPORATION (US) 1998-09-15 US claimed
WO-1997049740-A9 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM 1998-04-30 WO claimed
WO-1997049740-A1 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM NOVARTIS AG (CH) 1997-12-31 WO claimed
US-4853050-A Oil-in-water explosive composition containing asphalt ICI AUSTRALIAN OPERATORS PTY LTD. (AU) 1989-08-01 US claimed
EP-0067520-A2 An emulsion explosive and a method of making and stabilising such explosive AECI LIMITED (ZA) 1982-12-22 EP claimed
CN-116715699-A Oxazoline chiral N, P ligand, preparation method and application thereof 无锡学院 2023-09-08 CN disclosed
EP-0008507-A1 Derivatives of 2-oxazolines as antioxidants and compositions thereof UNIROYAL, INC. (US) 1980-03-05 EP disclosed